federal_register: E9-22292
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-22292 | Ophthalmic and Topical Dosage Form New Animal Drugs; Diclofenac | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The supplemental NADA provides for a revised human food safety warning for use of diclofenac sodium topical cream in horses. | 2009-09-16 | 2009 | 9 | https://www.federalregister.gov/documents/2009/09/16/E9-22292/ophthalmic-and-topical-dosage-form-new-animal-drugs-diclofenac | https://www.govinfo.gov/content/pkg/FR-2009-09-16/pdf/E9-22292.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The supplemental NADA provides for a revised human... |